Wednesday, June 19, 2013 Last update: 8:35 PM
Company Tech News as it Breaks
Trade Events
Puma Biotechnology, Inc.
News articles for Puma Biotechnology, Inc.:
Wednesday, June 5, 2013
- Puma Biotechnology to Present at Goldman Sachs Healthcare ConferencePuma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will present an ... read more
Wednesday, May 29, 2013
- Puma Biotechnology to Present at Jefferies Global Healthcare ConferencePuma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will present an ... read more
Friday, May 17, 2013
- Puma Biotechnology Comment on Trading ActivityPuma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, has been contacted by the New York Stock Exchange regarding today’s trading in the Company’s common stock. It ... read more
Tuesday, May 14, 2013
- Puma Biotechnology to Present at UBS Global Healthcare ConferencePuma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will present an ... read more
Thursday, May 9, 2013
- Puma Biotechnology Reports First Quarter 2013 Financial ResultsPuma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, reported financial results for the first quarter ended March 31, 2013. ... read more
Wednesday, May 8, 2013
- Puma Biotechnology to Present at Bank of America Merrill Lynch 2013 Health Care ConferencePuma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will present an ... read more
Monday, April 1, 2013
- Puma Biotechnology Reports Fourth Quarter and Full Year 2012 Financial ResultsPuma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company (“Puma” or the “Company”), today announced financial results for the fourth quarter and year ended December 31, ... read more
Tuesday, February 26, 2013
- Puma Biotechnology to Present at Cowen Healthcare ConferencePuma Biotechnology, Inc. (NYSE:PBYI), a development stage biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will present an ... read more
Wednesday, February 20, 2013
- Puma Biotechnology Announces Agreement with FDA on Special Protocol Assessment for Phase III Trial of PB272 (Neratinib) in HER2-Positive Metastatic Breast Cancer PatientsPuma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) under a Special ... read more
Wednesday, February 6, 2013
- Puma Biotechnology to Present at Leerink Swann Global Healthcare ConferencePuma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will present an ... read more